Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALBAVANCIN vs DANAPAROID: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DALBAVANCIN vs DANAPAROID: Safety Overview

Metric DALBAVANCIN DANAPAROID
Total FAERS Reports 1,107 170
Deaths Reported 54 67
Death Rate 4.9% 39.4%
Hospitalizations 288 75
Average Patient Age 61.0 yrs 63.4 yrs
% Female Patients 46.7% 63.1%
FDA Approval Date May 23, 2014 Dec 24, 1996
Manufacturer Fresenius Kabi USA, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Discontinued